United States Capecitabine Market Size & Outlook, 2025-2033


United States Capecitabine Market Insights

  • Reed Intelligence analysis indicates that the United States Capecitabine Market size, valued at USD 672.51 Million in 2024, is expected to expand to USD 1525.37 Million by 2033.
  • The United States market is forecasted to expand at a CAGR of 9.52% spanning 2026–2033.
  • Breast Cancer held the leading position among By Indication segments in 2024, based on market size.
  • Others is projected to post the fastest growth rate, sustaining its position as the most attractive By Indication segment during the forecast horizon.

Other Key Findings


  • United States accounted for 30.29% of the global Capecitabine Market size in 2024.
  • By 2033, United States is expected to remain the top global market in terms of size.
  • Within North America, United States is forecasted to dominate the regional Capecitabine Market size by 2033.
  • United States will be the fastest-growing market in North America, projected to achieve USD 1524.54 Million by 2033.

Report Summary

Report Scope Details
Base Year for Study 2024
Study Period 2021-2033
Historical Period 2021-2023
Forecast Period 2025-2033
Market Size In 2024 USD 672.51 Million
Market Size In 2033 USD 1525.37 Million
Largest segment Breast Cancer
Units Revenue in USD Million
CAGR 9.52% (2025-2033)
Segmnetation Covered
By Indication
  1. Breast Cancer
  2. Colorectal Cancer
  3. Gastric Cancer
  4. Others
By Drug Formulation
  1. Tablets
  2. Capsules
By End-User
  1. Hospitals
  2. Homecare
  3. Specialty Clinics
Report Coverage Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends